INFINITY PHARMACEUTICALS, INC. - FORM 10-K/A - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - March 15, 2011

Attached files

file filename
EX-31.1 - CERTIFICATION OF THE PEO AND PFO PURSUANT TO SECTION 302 - INFINITY PHARMACEUTICALS, INC.dex311.htm
EX-32.1 - CERTIFICATION OF THE PEO AND PFO PURSUANT TO SECTION 906 - INFINITY PHARMACEUTICALS, INC.dex321.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - INFINITY PHARMACEUTICALS, INC.dex211.htm
10-K/A - FORM 10-K/A - INFINITY PHARMACEUTICALS, INC.d10ka.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-156246 and Form S-8 Nos. 333-167488, 333-164207, 333-156641, 333-151135, 333-145306 and 333-138248) of Infinity Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 11, 2010, except for Note 2 as to which the date is March 15, 2011, with respect to the consolidated financial statements of Infinity Pharmaceuticals, Inc., and our report dated March 11, 2010 except for the effects of the material weakness described in the sixth paragraph of such report as to which the date is March 15, 2011, with respect to the effectiveness of internal control over financial reporting of Infinity Pharmaceuticals, Inc., included in this Annual Report (Form 10-K/A) for the year ended December 31, 2009.

/s/ Ernst & Young LLP

Boston, Massachusetts

March 15, 2011

INFINITY PHARMACEUTICALS, INC. Reports